These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 9920757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 4. WT1 splicing alterations in Wilms' tumors.
    Baudry D, Hamelin M, Cabanis MO, Fournet JC, Tournade MF, Sarnacki S, Junien C, Jeanpierre C.
    Clin Cancer Res; 2000 Oct 10; 6(10):3957-65. PubMed ID: 11051244
    [Abstract] [Full Text] [Related]

  • 5. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec 10; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 6. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM, Kenney MT, Simms LA, Smith SI, Kida Y, Smith PJ.
    Hum Mutat; 1995 Dec 10; 5(3):221-7. PubMed ID: 7599632
    [Abstract] [Full Text] [Related]

  • 7. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ, Haber D, Sklar J, Crum CP.
    Lab Invest; 1993 May 10; 68(5):528-36. PubMed ID: 8388523
    [Abstract] [Full Text] [Related]

  • 8. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D, Cabanis MO, Patte C, Zucker JM, Pein F, Fournet JC, Sarnacki S, Junien C, Jeanpierre C.
    Anticancer Res; 2003 May 10; 23(1A):475-8. PubMed ID: 12680252
    [Abstract] [Full Text] [Related]

  • 9. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710
    [Abstract] [Full Text] [Related]

  • 13. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR, Yun K, Williams BR, Eccles MR, Reeve AE.
    Lab Invest; 1994 Oct 01; 71(4):472-9. PubMed ID: 7967503
    [Abstract] [Full Text] [Related]

  • 14. The role of Wilms' tumor genes.
    Hirose M.
    J Med Invest; 1999 Aug 01; 46(3-4):130-40. PubMed ID: 10687307
    [Abstract] [Full Text] [Related]

  • 15. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
    Brenner B, Wildhardt G, Schneider S, Royer-Pokora B.
    Oncogene; 1992 Jul 01; 7(7):1431-3. PubMed ID: 1320246
    [Abstract] [Full Text] [Related]

  • 16. Wilms tumor and the WT1 gene.
    Lee SB, Haber DA.
    Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525
    [Abstract] [Full Text] [Related]

  • 17. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
    Baudry D, Faussillon M, Cabanis MO, Rigolet M, Zucker JM, Patte C, Sarnacki S, Boccon-Gibod L, Junien C, Jeanpierre C.
    Oncogene; 2002 Aug 15; 21(36):5566-73. PubMed ID: 12165855
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ, Saunders GF.
    Cancer Res; 1995 Nov 15; 55(22):5386-9. PubMed ID: 7585606
    [Abstract] [Full Text] [Related]

  • 19. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S, Tomlinson G, Nisen P, Haber DA.
    Cancer Res; 1993 Oct 15; 53(20):4757-60. PubMed ID: 8402654
    [Abstract] [Full Text] [Related]

  • 20. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB, Cohn SL, Tomlinson GE, Strong LC, Huff V.
    Oncogene; 1996 Sep 19; 13(6):1179-85. PubMed ID: 8808692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.